Modulating efferocytosis in the intestinal epithelial cells during colorectal cancer
This suggests that these two approaches to clearing apoptotic cells is not sufficient to alter CRC progression. Targeting other phagocytic cell types or using other models of CRC might reveal a role (or otherwise) for efferocytosis in mitigating CRC in the future.
Authors
- Tino Hochepied (ORCID: https://orcid.org/0000-0001-5897-2054)
- Tania Løve Aaes (ORCID: https://orcid.org/0000-0001-6813-8629)
- Lars Vereecke (ORCID: https://orcid.org/0000-0002-1593-862X)
- Sze Men Choi
- Kodi S. Ravichandran (ORCID: https://orcid.org/0000-0001-9049-1410)
- Laura Boeckaerts
- Yunus Incik
- Amanda Gonçalves
- Evi Scheirlinckx
Institutions
- Vlaams Instituut voor Biotechnologie (BE)
- Ghent University (BE)
- Cancer Research Institute Ghent (BE)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-03-09
- DOI
- https://doi.org/10.3389/fonc.2026.1740918
- Primary Topic
- Phagocytosis and Immune Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00